306428833	306428833	CD	B-NP	O
|	|	NN	I-NP	O
TCLH	TCLH	NN	I-NP	O
|	|	NN	I-NP	O
46947625	46947625	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7304072	7304072	CD	B-NP	O
|	|	CC	I-NP	O
2/22/2006	2/22/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/13/2006	1/13/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/17/2006	2/17/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
DEAL	DEAL	NN	B-NP	O
,	,	,	O	O
ROMAN	ROMAN	NN	B-NP	O
466-66-47-5	466-66-47-5	CD	I-NP	O
Derd	Derd	NNP	I-NP	O
T	T	NNP	I-NP	O
A	A	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/14/06	10/14/06	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TOOTHACRE	TOOTHACRE	NN	B-NP	O
,	,	,	O	O
SHELBY	SHELBY	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
,	,	,	O	O
Other	Other	JJ	B-NP	O
-	-	HYPH	I-NP	O
withhold	withhold	NN	I-NP	O
CPR	CPR	NN	I-NP	O
for	for	IN	B-PP	O
sudden	sudden	JJ	B-NP	O
death	death	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
81	81	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/15/06	4/15/06	CD	B-NP	O
by	by	IN	B-PP	O
KIRSCHBAUM	KIRSCHBAUM	NNP	B-NP	O
,	,	,	O	O
JESSIE	JESSIE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
220042020	220042020	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
,	,	,	I-NP	O
reg	reg	NN	I-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/2/06	1/2/06	CD	B-NP	O
by	by	IN	B-PP	O
CAPES	CAPES	NNP	B-NP	O
,	,	,	O	O
TITUS	TITUS	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
005414230	005414230	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEMENTAL	ELEMENTAL	NN	I-NP	O
CA	CA	NN	I-NP	O
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	B-protein
500	500	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
IRON	IRON	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Avoid	Avoid	NNP	I-NP	I-protein
milk	milk	NN	I-NP	I-protein
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
FOLATE	FOLATE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FOLIC	FOLIC	NN	I-NP	I-protein
ACID	ACID	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HYDRALAZINE	HYDRALAZINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
90	90	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

INSULIN	INSULIN	NNP	B-NP	B-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
Sliding	Sliding	NNP	I-NP	O
Scale	Scale	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
subcutaneously	subcutaneously	RB	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SC	SC	NN	I-NP	B-protein
AC	AC	NN	I-NP	I-protein
If	If	IN	B-SBAR	I-protein
BS	BS	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
125	125	CD	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
125-150	125-150	CD	B-NP	O
,	,	,	O	O
then	then	RB	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
151-200	151-200	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
201-250	201-250	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
251-300	251-300	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
301-350	301-350	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
If	If	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
351-400	351-400	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
and	and	CC	O	O
call	call	VB	B-VP	O
HO	HO	NN	B-NP	B-protein
Call	Call	NN	I-NP	I-protein
HO	HO	NN	I-NP	I-protein
if	if	IN	B-SBAR	O
BS	BS	NNP	B-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
400	400	CD	B-NP	O
ISORDIL	ISORDIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
85	85	CD	B-NP	O
LOPRESSOR	LOPRESSOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

DILANTIN	DILANTIN	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PHENYTOIN	PHENYTOIN	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
If	If	IN	B-ADJP	I-protein
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NNP	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/15/06	4/15/06	CD	B-NP	O
by	by	IN	B-PP	O
CUNNANE	CUNNANE	NN	B-NP	O
,	,	,	O	O
RALEIGH	RALEIGH	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
220042020	220042020	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENYTOIN	PHENYTOIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
,	,	,	I-NP	O
reg	reg	NN	I-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/2/06	1/2/06	CD	B-NP	O
by	by	IN	B-PP	O
GOICK	GOICK	NNP	B-NP	O
,	,	,	O	O
KENNETH	KENNETH	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
005414230	005414230	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENYTOIN	PHENYTOIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
PREDNISONE	PREDNISONE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
BICARBONATE	BICARBONATE	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/15/06	4/15/06	CD	B-NP	O
by	by	IN	B-PP	O
SOLDAN	SOLDAN	NNP	B-NP	O
,	,	,	O	O
TREVOR	TREVOR	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENYTOIN	PHENYTOIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
,	,	,	I-NP	O
reg	reg	NN	I-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
MVI	MVI	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/2/06	1/2/06	CD	B-NP	O
by	by	IN	B-PP	O
ARREZOLA	ARREZOLA	NNP	B-NP	O
,	,	,	O	O
CLINTON	CLINTON	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LOVENOX	LOVENOX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/26	11/26	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
STOP	STOP	NN	B-NP	B-protein
ONCE	ONCE	NN	I-NP	I-protein
INR	INR	NN	I-NP	I-protein
>	>	SYM	O	O
2.0	2.0	CD	B-NP	O
GLIPIZIDE	GLIPIZIDE	NN	I-NP	O
XL	XL	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
BACTRIM	BACTRIM	NNP	I-NP	O
DS	DS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRIMETHOPRIM/SULFAMETHOXAZOLE	TRIMETHOPRIM/SULFAMETHOXAZOLE	NNP	I-NP	O
DOU	DOU	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
3x/Week	3x/Week	NN	I-NP	O
M-W-F	M-W-F	NN	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/15/06	4/15/06	CD	B-NP	O
by	by	IN	B-PP	O
KAKEH	KAKEH	NNP	B-NP	O
,	,	,	O	O
BENTON	BENTON	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
220042020	220042020	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
,	,	,	I-NP	O
reg	reg	NN	I-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/2/06	1/2/06	CD	B-NP	O
by	by	IN	B-PP	O
HINTON	HINTON	NNP	B-NP	O
,	,	,	O	O
PETE	PETE	NNP	B-NP	O
K.	K.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
SULFAMETHOXAZOLE	SULFAMETHOXAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
FLOVENT	FLOVENT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
220	220	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PLAVIX	PLAVIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DUONEB	DUONEB	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
AND	AND	CC	O	O
IPRATROPIUM	IPRATROPIUM	NNP	B-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NN	I-NP	O
NEB	NEB	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
DARBEPOETIN	DARBEPOETIN	NN	I-NP	O
ALFA	ALFA	NN	I-NP	O
25	25	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QWEEK	QWEEK	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
ordering	order	VBG	B-VP	O
:	:	:	O	O
Renal	Renal	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
Last	Last	JJ	I-NP	O
known	know	VBN	I-NP	O
Hgb	Hgb	NN	I-NP	B-protein
level	level	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
order	order	NN	B-NP	O
:	:	:	O	O
9.2	9.2	CD	B-NP	O
g/dL	g/dL	NN	I-NP	O
on	on	IN	B-PP	O
8/6/06	8/6/06	CD	B-NP	O
at	at	IN	B-PP	O
HMH	HMH	NN	B-NP	O
Diagnosis	Diagnosis	NN	I-NP	O
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
Renal	Renal	JJ	I-NP	O
Failure	Failure	NN	I-NP	O
585	585	CD	I-NP	O
Treatment	Treatment	NN	I-NP	O
Cycle	Cycle	NN	I-NP	O
:	:	:	O	O
Initiation	Initiation	NN	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/14/06	10/14/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
reg	reg	NN	B-NP	O
home	home	NN	I-NP	O
meds	med	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
NAS	NAS	NN	I-NP	B-protein
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
ADA	ADA	NN	I-NP	O
1600	1600	CD	B-NP	O
cals/daycals/dy	cals/daycals/dy	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
/	/	SYM	B-NP	O
Renal	Renal	JJ	I-NP	O
diet	diet	NN	I-NP	O
/	/	SYM	B-NP	O
LOW	LOW	NN	I-NP	O
POTASSIUM	POTASSIUM	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
I	I	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FDI	FDI	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ACTIVITY	ACTIVITY	NNP	I-NP	O
:	:	:	O	O
walking	walk	VBG	B-VP	O
with	with	IN	B-PP	O
walker	walker	NN	B-NP	O
and	and	CC	I-NP	O
2L	2L	NN	I-NP	B-protein
O2	O2	NN	I-NP	I-protein
with	with	IN	B-PP	O
assist	assist	NN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Rodney	Rodney	NNP	I-NP	O
Ahumada	Ahumada	NNP	I-NP	O
9/9	9/9	CD	I-NP	O
@	@	CD	I-NP	O
3	3	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Gustavo	Gustavo	NNP	I-NP	O
Klecha	Klecha	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
renal	renal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
5/21	5/21	CD	I-NP	O
@	@	NN	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Pledger	Pledger	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
11/18/06	11/18/06	CD	I-NP	O
at	at	IN	B-PP	O
1pm	1pm	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
4/1/05	4/1/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
1	1	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Rehab	Rehab	NN	B-NP	O
facility	facility	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Dr.	Dr.	NNP	B-NP	O
Everette	Everette	NNP	I-NP	O
Lambrakis	Lambrakis	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
ACE	ACE	NNP	B-NP	O
Inhibitor	Inhibitor	NNP	I-NP	O
,	,	,	O	O
DICLOXACILLIN	DICLOXACILLIN	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
ANEMIA	ANEMIA	NNP	I-NP	O
CRI	CRI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Cr	Cr	NNP	I-NP	O
1.7	1.7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
seizures	seizure	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
partial	partial	JJ	B-NP	O
seizures	seizure	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dvt	dvt	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
calf	calf	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
colon	colon	NN	I-NP	O
adenoma	adenoma	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
colonic	colonic	JJ	I-NP	O
polyps	polyp	NNS	I-NP	O
-RRB-	-RRB-	TO	B-PP	O
TAH	TAH	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	SYM	B-VP	O
PPM	PPM	NN	B-NP	B-protein
3/15	3/15	CD	I-NP	I-protein
for	for	IN	B-PP	O
SSS	SSS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NNP	B-NP	O
1997	1997	CD	I-NP	O
,	,	,	I-NP	O
4/12	4/12	CD	I-NP	O
with	with	IN	B-PP	O
stents	stent	NNS	B-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
,	,	,	O	O
D1	D1	NN	B-NP	B-protein
,	,	,	O	O
LCx	LCx	NN	B-NP	O
severe	severe	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
sarcoidosis	sarcoidosis	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
Increased	Increased	NNP	B-NP	O
Cr	Cr	NNP	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
Ms	M	NNS	B-NP	O
Commins	Commin	NNS	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
74	74	CD	I-NP	O
yo	yo	NN	I-NP	O
female	female	JJ	B-ADJP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
LAD	LAD	NN	I-NP	O
stent	stent	NN	I-NP	O
4/12	4/12	CD	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
EF	EF	NN	I-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
CRI	CRI	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
Cr	Cr	NN	I-NP	B-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
1.9-2	1.9-2	CD	I-NP	I-protein
.4	.4	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
elevated	elevate	VBN	B-NP	O
K	K	NN	I-NP	O
and	and	CC	I-NP	O
Cr	Cr	NN	I-NP	O
and	and	CC	O	O
increasing	increase	VBG	B-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
reports	report	VBZ	B-VP	O
1	1	CD	B-NP	O
yr	yr	NN	I-NP	O
of	of	IN	B-PP	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
PO	PO	NN	B-NP	B-protein
more	more	RBR	B-ADJP	O
notable	notable	JJ	I-ADJP	O
within	within	IN	B-PP	O
past	past	JJ	B-NP	B-protein
1-2	1-2	CD	I-NP	I-protein
wks	wk	NNS	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
ROS	ROS	NN	B-NP	O
+	+	SYM	B-NP	O
sweating	sweating	NN	I-NP	O
@	@	SYM	O	O
night	night	NN	B-NP	O
o/w	o/w	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
off	off	RP	B-PRT	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	NN	B-NP	O
per	per	IN	B-PP	O
renal	renal	JJ	B-NP	O
input	input	NN	I-NP	O
because	because	IN	B-SBAR	O
on	on	IN	B-PP	O
recent	recent	JJ	B-NP	O
admit	admit	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
10/5	10/5	CD	I-NP	O
-RRB-	-RRB-	HYPH	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
Cr	Cr	NNP	B-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
prerenal	prerenal	JJ	B-ADJP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
when	when	WRB	B-ADVP	O
lasix	lasix	NN	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	I-NP	O
pressure	pressure	NN	I-NP	O
or	or	CC	I-NP	O
palp	palp	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
.	.	.	O	O

***	***	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
EF	EF	NN	I-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
10/25	10/25	CD	B-NP	O
by	by	IN	B-PP	O
TTE	TTE	NN	B-NP	O
showing	show	VBG	B-VP	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR/TR	MR/TR	NN	I-NP	O
,	,	,	O	O
HK	HK	NN	B-NP	O
inf	inf	NN	I-NP	O
septum	septum	NN	I-NP	O
&	&	CC	O	O
posterior	posterior	RB	B-ADJP	O
basal	basal	JJ	I-ADJP	O
,	,	,	O	O
MI	MI	NN	B-NP	B-DNA
1997	1997	CD	I-NP	I-DNA
,	,	,	O	O
s/p	s/p	NN	B-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
D1	D1	NN	B-NP	B-protein
,	,	,	O	O
LCx	LCx	NN	B-NP	O
stents	stent	NNS	I-NP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	O	O
Anemia	Anemia	NNP	B-NP	O
,	,	,	O	O
CRI	CRI	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
baseline	baseline	NN	I-NP	O
Cr	Cr	NNP	B-NP	O
1.9-2	1.9-2	CD	I-NP	O
.4	.4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
H/o	H/o	NN	B-NP	O
partial	partial	JJ	I-NP	O
seizures	seizure	NNS	I-NP	O
on	on	IN	B-PP	O
dilantin	dilantin	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
DVT	DVT	NN	I-NP	I-protein
L	L	NN	I-NP	I-protein
calf	calf	NN	I-NP	I-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
TAH	TAH	NN	I-NP	O
/	/	SYM	B-NP	O
appy	appy	NN	I-NP	O
,	,	,	O	O
H/o	H/o	NNP	B-NP	O
cervical	cervical	JJ	I-NP	O
CA	CA	NN	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
2-3	2-3	NN	I-NP	O
mm	mm	NN	I-NP	O
polyp	polyp	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
SSS	SSS	NN	B-NP	O
s/p	s/p	NN	I-NP	O
DDD	DDD	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
Sarcoid	Sarcoid	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
severe	severe	JJ	B-NP	O
restrictive	restrictive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
dz	dz	NN	I-NP	O
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
,	,	,	O	O
dyslipidemia	dyslipidemia	NN	B-NP	O
***	***	SYM	I-NP	O
Admit	Admit	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
97.2	97.2	CD	I-NP	O
BP	BP	NN	I-NP	O
147/66	147/66	CD	B-NP	O
P	P	NN	I-NP	B-protein
52	52	CD	B-NP	I-protein
R	R	NN	I-NP	I-protein
18	18	CD	B-NP	I-protein
100	100	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
RA	RA	NN	I-NP	I-protein
Gen	Gen	NNP	I-NP	O
:	:	:	O	O
Frail	Frail	NNP	B-NP	O
appearing	appear	VBG	B-VP	O
elderly	elderly	JJ	B-NP	O
female	female	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
+	+	SYM	B-NP	O
?	?	.	O	O

exopthalmos	exopthalmo	NNS	B-NP	O
,	,	,	O	O
anicteric	anicteric	JJ	B-NP	O
,	,	,	I-NP	O
mmm	mmm	NN	I-NP	O
Neck	Neck	NNP	I-NP	O
:	:	:	O	O
thyromegaly	thyromegaly	RB	B-ADVP	O
vs.	vs.	IN	B-PP	O
submandibular	submandibular	JJ	B-NP	O
fullness	fullness	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
nodules	nodule	NNS	I-NP	O
,	,	,	O	O
non-painful	non-painful	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
bilateral	bilateral	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
to	to	TO	B-PP	O
apeces	apece	NNS	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
HSM	HSM	NNP	I-NP	O
@	@	NNP	I-NP	O
LLSB	LLSB	NNP	I-NP	O
,	,	,	O	O
JVP	JVP	NNP	B-NP	O
@	@	NNP	I-NP	O
ear	ear	NNP	I-NP	O
Abd	Abd	NNP	I-NP	O
:	:	:	O	O
nt	nt	NN	B-NP	O
,	,	,	O	O
nd	nd	NN	B-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
hyperactive	hyperactive	JJ	I-NP	O
BS	BS	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hsm	hsm	NN	I-NP	O
Ext	Ext	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
c/c/e	c/c/e	NN	I-NP	O
,	,	,	O	O
**	**	SYM	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
atrial	atrial	JJ	B-NP	O
paced	paced	NN	I-NP	O
,	,	,	O	O
not	not	RB	O	O
capturing	capture	VBG	B-VP	O
SB	SB	NN	B-NP	B-protein
@	@	,	I-NP	O
56	56	CD	I-NP	O
,	,	,	I-NP	O
nl	nl	NN	I-NP	O
axis	axis	NN	I-NP	O
,	,	,	O	O
nl	nl	NN	B-NP	O
intervals	interval	NNS	I-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
st-t	st-t	JJ	I-NP	O
wave	wave	NN	I-NP	O
changes	change	NNS	I-NP	O
***	***	SYM	B-NP	O
Consults	Consult	NNS	I-NP	O
:	:	:	O	O
Renal	Renal	JJ	B-NP	O
,	,	,	I-NP	O
Cards	Card	NNS	I-NP	O
,	,	,	I-NP	O
EP	EP	NN	I-NP	B-protein
,	,	,	I-NP	O
Nutrition	Nutrition	NN	I-NP	O
,	,	,	I-NP	O
PT	PT	NN	I-NP	O
****	****	SYM	I-NP	O
Imp	Imp	NNP	B-NP	O
:	:	:	O	O
74	74	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
sarcoid	sarcoid	NN	I-NP	O
and	and	CC	I-NP	O
CHF	CHF	NN	I-NP	B-protein
and	and	CC	I-NP	O
CRI	CRI	NN	I-NP	B-protein
here	here	RB	B-ADVP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
after	after	IN	B-PP	O
stopping	stop	VBG	B-VP	O
lasix	lasix	CD	B-NP	O
several	several	JJ	I-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
clinical	clinical	JJ	B-NP	O
exam	exam	NN	I-NP	O
and	and	CC	I-NP	O
CXR	CXR	NN	I-NP	B-protein
it	it	PRP	B-NP	O
appears	appear	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
CHF	CHF	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
worse	worse	JJR	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Cardiovascular	Cardiovascular	NNP	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
mildly	mildly	RB	B-NP	O
decompensated	decompensate	VBN	I-NP	O
CHF	CHF	NN	I-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
more	more	RBR	B-NP	O
aggressive	aggressive	JJ	I-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
with	with	IN	B-PP	O
lasix	lasix	CD	B-NP	O
40	40	CD	I-NP	O
iv	iv	NN	I-NP	O
BID	BID	NN	I-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
bid	bid	NN	I-NP	O
on	on	IN	B-PP	O
HD2	HD2	NN	B-NP	B-protein
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
meeting	meet	VBG	I-VP	O
her	her	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
goal	goal	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
service	service	NN	I-NP	O
consulting	consulting	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
increase	increase	NN	B-NP	O
to	to	TO	B-VP	O
lasix	lasix	VB	I-VP	O
drip	drip	NN	B-NP	O
at	at	IN	B-PP	O
15/hr	15/hr	NN	B-NP	O
on	on	IN	B-PP	O
HD3	HD3	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
i/o	i/o	NN	B-NP	B-protein
goal	goal	NN	I-NP	I-protein
1-2	1-2	CD	I-NP	I-protein
l	l	NN	I-NP	I-protein
neg	neg	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
and	and	CC	B-PP	O
by	by	IN	B-PP	O
HD5	HD5	NN	B-NP	B-protein
was	be	VBD	B-VP	O
near	near	IN	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
49kg	49kg	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
PO	PO	NN	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
80	80	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
adequate	adequate	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Hydralazine	Hydralazine	NN	B-NP	O
,	,	,	O	O
lopressol	lopressol	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Isordil	Isordil	NN	B-NP	O
on	on	IN	B-PP	O
HD3	HD3	NN	B-NP	B-protein
,	,	,	O	O
titrated	titrate	VBN	B-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
tid	tid	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
MI	MI	NN	B-NP	O
with	with	IN	B-PP	O
stents	stent	NNS	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Asa	Asa	NNP	B-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
fell	fall	VBD	B-VP	O
from	from	IN	B-PP	O
3500	3500	CD	B-NP	O
on	on	IN	B-PP	O
admit	admit	NN	B-NP	O
to	to	TO	B-PP	O
1500	1500	CD	B-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
wt	wt	NN	I-NP	O
on	on	IN	B-PP	O
HD6	HD6	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
paced	pace	VBN	I-VP	O
intermittent	intermittent	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
pacer	pacer	NN	I-NP	O
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
past	past	NN	B-NP	O
for	for	IN	B-PP	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
,	,	,	O	O
functioning	function	VBG	B-VP	O
properly	properly	RB	B-ADVP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
backup	backup	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
acute	acute	JJ	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
RF	RF	NN	I-NP	O
possibly	possibly	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-VP	O
poor	poor	VB	I-VP	O
for	for	IN	B-PP	O
forward	forward	JJ	B-NP	O
flow	flow	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	O
decompensation	decompensation	NN	I-NP	O
.	.	.	O	O

Cr	Cr	NN	B-NP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
3.6	3.6	CD	B-NP	O
on	on	IN	B-PP	O
HD3	HD3	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
as	as	IN	B-SBAR	O
she	she	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
Cr	Cr	NN	I-NP	B-protein
stabilized	stabilize	VBD	B-VP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
following	follow	VBG	I-VP	O
and	and	CC	O	O
recommended	recommend	VBN	B-NP	O
diureses	diures	NNS	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
K	K	NN	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
good	good	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
withholding	withhold	VBG	B-VP	O
ace	ace	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharge	discharge	NN	B-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Cr	Cr	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
3.5	3.5	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
probably	probably	RB	I-VP	O
not	not	RB	I-VP	O
go	go	VB	I-VP	O
on	on	IN	B-PP	O
Ace	Ace	NNP	B-NP	O
Inhibitor	Inhibitor	NNP	I-NP	O
again	again	RB	B-ADVP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
FEN	FEN	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
Hyperkalemia	Hyperkalemia	NN	I-NP	O
w/o	w/o	NN	I-NP	O
EKG	EKG	NN	I-NP	O
change	change	NN	I-NP	O
.	.	.	O	O

Improved	Improve	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

Rec	Rec	NNP	B-NP	O
'd	'd	MD	O	O
Kayexylate	Kayexylate	NNP	O	O
in	in	IN	B-PP	O
ED	ED	NNP	B-NP	O
.	.	.	O	O

Now	Now	RB	B-ADVP	O
improved	improve	VBN	B-ADJP	O
.	.	.	O	O

Follow	Follow	NNP	B-NP	O
K/Mg	K/Mg	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
Ace	Ace	NNP	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
K-sparing	K-sparing	NN	I-NP	O
diuretic	diuretic	JJ	B-ADJP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ENDO	ENDO	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
glipizide	glipizide	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
HD5	HD5	NN	B-NP	B-protein
.	.	.	O	O

Add	Add	NN	B-NP	O
insulin	insulin	NN	I-NP	O
SS	SS	NN	I-NP	O
for	for	IN	B-PP	O
tight	tight	JJ	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

TSH	TSH	NN	B-NP	O
high	high	JJ	I-NP	O
.	.	.	O	O

T4	T4	NN	B-NP	O
low	low	JJ	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
rechecked	rechecke	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
before	before	IN	B-PP	O
initiating	initiate	VBG	B-VP	O
therapy	therapy	NN	B-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Heme	Heme	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
ON	ON	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
for	for	IN	B-PP	O
history	history	NN	B-NP	O
DVT	DVT	NN	I-NP	O
.	.	.	O	O

Held	Held	NN	B-NP	O
on	on	IN	B-PP	O
HD3	HD3	NN	B-NP	B-protein
for	for	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-DNA
3.1	3.1	CD	I-NP	I-DNA
and	and	CC	O	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
shortly	shortly	RB	B-ADVP	O
after	after	IN	B-SBAR	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
1.4	1.4	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
1.5	1.5	CD	B-NP	O
U	U	NN	I-NP	O
of	of	IN	B-PP	O
PRBC	PRBC	NN	B-NP	B-protein
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
HCT	HCT	NN	I-NP	O
>	>	JJR	B-NP	O
30	30	CD	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
30.8	30.8	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
anemia	anemia	NN	I-NP	O
is	be	VBZ	B-VP	O
2/2	2/2	CD	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
darbopoetin	darbopoetin	NN	B-NP	B-protein
25	25	CD	I-NP	I-protein
qwk	qwk	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
clot	clot	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
Right	Right	NN	I-NP	B-DNA
external	external	JJ	I-NP	I-DNA
jugular	jugular	JJ	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
of	of	IN	B-PP	O
prior	prior	JJ	B-NP	O
IV	IV	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
place	place	NN	B-NP	O
on	on	IN	B-PP	O
renal	renal	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
until	until	IN	B-PP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
>	>	SYM	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
stopped	stop	VBN	I-VP	O
once	once	RB	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
>	>	JJR	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Neuro	Neuro	NN	I-NP	B-protein
-	-	HYPH	B-ADJP	O
On	On	IN	B-PP	O
dilantin	dilantin	NN	B-NP	O
for	for	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
partial	partial	JJ	B-NP	O
seizures	seizure	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Code	Code	NNP	I-NP	O
-	-	:	O	O
no	no	DT	B-NP	O
CPR	CPR	NN	I-NP	B-protein
if	if	IN	B-SBAR	O
sudden	sudden	JJ	B-NP	O
death	death	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
intubation/defibrillation	intubation/defibrillation	NN	B-NP	O
ok	ok	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
instability	instability	NN	B-NP	O
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
Wadesdi	Wadesdi	NNP	B-NP	O
Ckgart	Ckgart	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
euvolemic	euvolemic	JJ	I-NP	O
state	state	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
49kg	49kg	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
80	80	CD	B-NP	O
po	po	NN	I-NP	O
lasix	lasix	CD	B-NP	O
bid	bid	NN	I-NP	O
unless	unless	IN	B-SBAR	O
her	her	PRP$	B-NP	O
Cr	Cr	NN	I-NP	B-protein
rises	rise	VBZ	B-VP	O
above	above	IN	B-PP	O
new	new	JJ	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
3.5	3.5	CD	B-NP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
gains	gain	VBZ	B-VP	O
weight	weight	NN	B-NP	O
or	or	CC	O	O
shows	show	VBZ	B-VP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
new	new	JJ	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
stopped	stop	VBN	I-VP	O
once	once	RB	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
>	>	JJR	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
dose	dose	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
adjusted	adjust	VBN	I-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
INR	INR	NN	B-NP	O
goal	goal	NN	I-NP	O
2-3	2-3	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
renal	renal	JJ	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
potassium	potassium	NN	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
but	but	CC	B-PP	O
with	with	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
caloric	caloric	JJ	I-NP	O
supplements	supplement	NNS	I-NP	O
like	like	IN	B-PP	O
GLUCERNA	GLUCERNA	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
receive	receive	VB	I-VP	O
a	a	DT	B-NP	O
HOT	HOT	NN	I-NP	O
PACK	PACK	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
2-3x	2-3x	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
and	and	CC	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
vein	vein	NN	I-NP	O
before	before	IN	B-PP	O
blood	blood	NN	B-NP	O
draw	draw	NN	I-NP	O
for	for	IN	B-PP	O
comfort	comfort	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
receive	receive	VB	I-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
daily	daily	RB	B-ADVP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
gait	gait	NN	B-NP	O
stability	stability	NN	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
safety	safety	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
good	good	JJ	B-NP	O
O2	O2	NN	I-NP	O
sats	sat	NNS	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	B-protein
O2	O2	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
at	at	IN	B-PP	O
2L	2L	NN	B-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
for	for	IN	B-PP	O
meds	med	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
alone	alone	RB	B-ADVP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
ideal	ideal	JJ	B-ADJP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
relative	relative	JJ	I-NP	O
stay	stay	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
going	go	VBG	B-VP	O
home	home	NN	B-NP	O
.	.	.	O	O

resume	resume	VB	B-VP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
upon	upon	IN	B-PP	O
dc	dc	NN	B-NP	B-cell_type
.	.	.	O	O

contact	contact	NN	B-NP	O
:	:	:	O	O
son	son	NN	B-NP	O
Soulliere	Soulliere	NNP	I-NP	O
in	in	IN	B-PP	O
Ta	Ta	NNP	B-NP	O
Broke	Broke	NNP	I-NP	O
Ver	Ver	NNP	I-NP	O
O	O	NNP	I-NP	O
Arb	Arb	NNP	I-NP	O
Ca	Ca	NNP	I-NP	O
283-652-3240	283-652-3240	CD	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
or	or	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
experience	experience	VBP	B-VP	O
worsening	worsen	VBG	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
fever	fever	RB	B-ADVP	O
over	over	IN	B-PP	O
100.5	100.5	CD	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
urine	urine	NN	B-NP	O
output	output	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
over	over	IN	B-PP	O
5	5	CD	B-NP	O
pounds	pound	NNS	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
keep	keep	VB	I-VP	O
your	your	PRP$	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appts	appt	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Zari	Zari	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Piquette	Piquette	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
renal	renal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cardiology	cardiology	NN	B-NP	O
.	.	.	O	O

as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
d/c	d/c	NN	I-NP	O
Lovenox	Lovenox	NN	I-NP	O
once	once	RB	B-ADVP	O
INR	INR	NN	B-NP	B-protein
>	>	JJR	B-NP	O
2	2	CD	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
renal	renal	JJ	I-NP	O
,	,	,	I-NP	O
diabetic	diabetic	JJ	I-NP	O
,	,	,	I-NP	O
low	low	JJ	I-NP	O
potassium	potassium	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
salt	salt	NN	I-NP	O
diet	diet	NN	I-NP	O
with	with	IN	B-PP	O
glucerna	glucerna	NN	B-NP	B-protein
supplements	supplement	NNS	I-NP	I-protein
3	3	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
continue	continue	JJ	I-NP	O
PT	PT	NN	I-NP	O
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
of	of	IN	B-PP	O
safe	safe	JJ	B-NP	O
ambulation	ambulation	NN	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
safety	safety	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
good	good	JJ	B-NP	O
O2	O2	NN	I-NP	O
sat	sit	VBD	B-VP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
COREY	COREY	NNP	B-NP	O
,	,	,	O	O
REYNALDO	REYNALDO	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SS13	SS13	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/14/06	10/14/06	CD	I-NP	O
@	@	SYM	B-NP	O
03	03	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

